Informa (LON:INF) Price Target Raised to GBX 1,000 at Citigroup

Informa (LON:INF) had its target price raised by Citigroup from GBX 975 to GBX 1,000 in a report released on Thursday morning, Marketbeat.com reports. They currently have a neutral rating on the stock.

Other equities research analysts also recently issued reports about the stock. Panmure Gordon reiterated a “buy” rating and set a GBX 1,200 price objective on shares of Informa in a research note on Wednesday, November 19th. UBS Group reaffirmed a “buy” rating and set a GBX 1,055 price target on shares of Informa in a report on Friday, November 7th. Berenberg Bank reiterated a “buy” rating and set a GBX 1,030 price target on shares of Informa in a research report on Wednesday. JPMorgan Chase & Co. lowered their price objective on shares of Informa from GBX 1,345 to GBX 1,330 and set an “overweight” rating for the company in a research report on Monday, January 12th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Informa from GBX 1,000 to GBX 1,140 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. Six equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 1,097.86.

Informa Stock Performance

INF opened at GBX 933.20 on Thursday. The company has a debt-to-equity ratio of 31.98, a quick ratio of 1.70 and a current ratio of 0.56. Informa has a 52-week low of GBX 634.20 and a 52-week high of GBX 1,000. The firm has a market cap of £11.93 billion, a P/E ratio of 169.67, a price-to-earnings-growth ratio of 0.75 and a beta of 1.12. The business’s fifty day moving average is GBX 905.79 and its 200-day moving average is GBX 901.44.

About Informa

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.